Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'.
复制标题
DOI：
10.1186/1745-6215-9-20
复制
发表时间：
2008-04-18
期刊：
影响因子：
2.5
通讯作者：
Schulz KF
中科院分区：
文献类型：
--
作者：
Hopewell S;Altman DG;Moher D;Schulz KF
CONSORT声明提供了报告随机对照试验的建议。我们评估了发表随机试验报告的领先医学期刊将CONSORT建议纳入其期刊和编辑过程的程度。本文报道了两项观察性研究。研究1：我们检查了165种高影响因子医学期刊的“作者须知”的在线版本，并提取了所有提及CONSORT声明或CONSORT扩展论文的文本。还搜索并提取了国际医学期刊编辑委员会（ICMJE）或临床试验注册的任何提及。研究2：我们调查了165种期刊的主编或编辑部，了解期刊对CONSORT建议的认可程度，以及将其纳入编辑和同行评审流程的情况。研究1：38%（62/165）的期刊在其在线“作者须知”中提到了CONSORT声明;其中37%（23/62）表示这是一项要求，63%（39/62）的建议不太明确。很少有期刊提到CONSORT扩展论文。与未提及CONSORT的期刊相比，提及CONSORT的期刊更可能提及ICMJE指南（RR 2.16; 95% CI 1.51 - 3.08）和临床试验注册（RR 3.67; 95% CI 2.36 - 5.71）。研究2：39%（64/165）的期刊回应了在线调查，大多数是期刊编辑。88%（50/57）的期刊建议作者遵守CONSORT声明; 62%（35/56）的期刊表示他们会要求这一点。41%（22/53）报告将CONSORT纳入同行评审过程，47%（25/53）报告将其纳入编辑过程。百分之八十一（47/58）报告说，包括CONSORT在他们的“指示作者”，虽然有一些不一致的交叉检查信息时，该杂志的网站。69%（31/45）的期刊推荐作者遵守CONSORT扩展的群集试验，60%（27/45）的危害和42%（19/45）的非劣效性和等效性试验。很少有期刊在他们的“作者须知”中提到这些扩展。期刊应该更明确地提出作者对CONSORT声明和相关CONSORT扩展论文的建议和期望。
The CONSORT Statement provides recommendations for reporting randomized controlled trials. We assessed the extent to which leading medical journals that publish reports of randomized trials incorporate the CONSORT recommendations into their journal and editorial processes. This article reports on two observational studies. Study 1: We examined the online version of 'Instructions to Authors' for 165 high impact factor medical journals and extracted all text mentioning the CONSORT Statement or CONSORT extension papers. Any mention of the International Committee of Medical Journal Editors (ICMJE) or clinical trial registration were also sought and extracted. Study 2: We surveyed the editor-in-chief, or editorial office, for each of the 165 journals about their journal's endorsement of CONSORT recommendations and its incorporation into their editorial and peer-review processes. Study 1: Thirty-eight percent (62/165) of journals mentioned the CONSORT Statement in their online 'Instructions to Authors'; of these 37% (23/62) stated this was a requirement, 63% (39/62) were less clear in their recommendations. Very few journals mentioned the CONSORT extension papers. Journals that referred to CONSORT were more likely to refer to ICMJE guidelines (RR 2.16; 95% CI 1.51 to 3.08) and clinical trial registration (RR 3.67; 95% CI 2.36 to 5.71) than those journals which did not. Study 2: Thirty-nine percent (64/165) of journals responded to the on-line survey, the majority were journal editors. Eighty-eight percent (50/57) of journals recommended authors comply with the CONSORT Statement; 62% (35/56) said they would require this. Forty-one percent (22/53) reported incorporating CONSORT into their peer-review process and 47% (25/53) into their editorial process. Eighty-one percent (47/58) reported including CONSORT in their 'Instructions to Authors' although there was some inconsistency when cross checking information on the journal's website. Sixty-nine percent (31/45) of journals recommended authors comply with the CONSORT extension for cluster trials, 60% (27/45) for harms and 42% (19/45) for non-inferiority and equivalence trials. Few journals mentioned these extensions in their 'Instructions to Authors'. Journals should be more explicit in their recommendations and expectations of authors regarding the CONSORT Statement and related CONSORT extensions papers.
登录
查看更多内容
影响因子：
168.9
作者：
Moher, D;Schulz, KF;Altman, DG
通讯作者：
Altman, DG
影响因子：
105.7
作者：
Campbell, MK;Elbourne, DR;Altman, DG
通讯作者：
Altman, DG
影响因子：
120.7
作者：
Begg, C;Cho, M;Stroup, DF
通讯作者：
Stroup, DF
影响因子：
39.2
作者：
Gagnier, JJ;Boon, H;Bombardier, C
通讯作者：
Bombardier, C
影响因子：
15.8
作者：
Hopewell, Sally;Clarke, Mike;Schulz, Kenneth F.
通讯作者：
Schulz, Kenneth F.